MedTrace Logo

Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study

NCT02675010 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2016-03-16

No results posted yet for this study

Summary

There are controversies about the best sites -biopsy based -tests for H pylori associated gastritis. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.

Conditions

  • Helicobacter Pylori
  • Gastric Antrum
  • CORPUS BIOPSIES

Interventions

OTHER

ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • MOHAMED ABDELLATIF, ASS PROF · MANSOURA FACULTY OF MEDICINE

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02675010 on ClinicalTrials.gov